These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34344784)

  • 41. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
    Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
    PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton pump inhibitor: The dual role in gastric cancer.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2019 May; 25(17):2058-2070. PubMed ID: 31114133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Reduction in Gastric Atrophy after
    Niikura R; Hayakawa Y; Hirata Y; Ogura K; Fujishiro M; Yamada A; Ushiku T; Konishi M; Fukayama M; Koike K
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
    Kim N
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1287-1295. PubMed ID: 30828872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response to letter to the editor by Moayyedi
    Cheung KS; Leung WK
    Gut; 2019 Sep; 68(9):1721-1722. PubMed ID: 30121628
    [No Abstract]   [Full Text] [Related]  

  • 47. Editorial: PPIs and gastric cancer-Are we dealing with a carcinogen?
    Malfertheiner P; Schulz C; Howden CW
    Aliment Pharmacol Ther; 2023 Nov; 58(10):1099-1100. PubMed ID: 37885170
    [No Abstract]   [Full Text] [Related]  

  • 48. Can We StoP Worrying about Long-term PPIs and Gastric Cancer Risk?
    Richman CM; Leiman DA
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1127-1129. PubMed ID: 37655427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
    Dickey W; Kenny BD; McConnell JB
    Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
    Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.
    Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
    Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
    Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.
    Waldum HL; Rehfeld JF
    Scand J Gastroenterol; 2019 Sep; 54(9):1118-1123. PubMed ID: 31524029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening and eradication of
    Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
    Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Proton Pump Inhibitor Therapy,
    Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
    Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastroesophageal reflux disease.
    Fernández-Fernández FJ
    N Engl J Med; 2009 Feb; 360(7):729; author reply 729-30. PubMed ID: 19222130
    [No Abstract]   [Full Text] [Related]  

  • 58. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
    Cheng HC; Tsai YC; Yang HB; Yeh YC; Chang WL; Kuo HY; Lu CC; Sheu BS
    Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28326664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.
    Hwang JJ; Lee DH; Kang KK; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(13):3936-43. PubMed ID: 25852279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric foveolar metaplasia and gastric heterotopia in the duodenum: no evidence of an etiologic role for Helicobacter pylori.
    Genta RM; Kinsey RS; Singhal A; Suterwala S
    Hum Pathol; 2010 Nov; 41(11):1593-600. PubMed ID: 20656325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.